Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships
- PMID: 19356901
- PMCID: PMC2905668
- DOI: 10.1016/j.jclinepi.2008.12.005
Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships
Abstract
The gold standard of study design for treatment evaluation is widely acknowledged to be the randomized controlled trial (RCT). Trials allow for the estimation of causal effect by randomly assigning participants either to an intervention or comparison group; through the assumption of "exchangeability" between groups, comparing the outcomes will yield an estimate of causal effect. In the many cases where RCTs are impractical or unethical, instrumental variable (IV) analysis offers a nonexperimental alternative based on many of the same principles. IV analysis relies on finding a naturally varying phenomenon, related to treatment but not to outcome except through the effect of treatment itself, and then using this phenomenon as a proxy for the confounded treatment variable. This article demonstrates how IV analysis arises from an analogous but potentially impossible RCT design, and outlines the assumptions necessary for valid estimation. It gives examples of instruments used in clinical epidemiology and concludes with an outline on estimation of effects.
References
-
- Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561–70. - PubMed
-
- Robins JM. Correcting for non-compliance in randomized trials using structural nested mean models. Commun Statist Theory Meth. 1994;23:2379–412.
-
- Walker AM. Confounding by indication. Epidemiology. 1994;7:335–6. - PubMed
-
- Schneweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin epidemiol. 2005;58:323–37. - PubMed
-
- Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin epidemiol. 2006;59:819–28. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources